These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4515875)

  • 21. An M2-V27A channel blocker demonstrates potent in vitro and in vivo antiviral activities against amantadine-sensitive and -resistant influenza A viruses.
    Hu Y; Musharrafieh R; Ma C; Zhang J; Smee DF; DeGrado WF; Wang J
    Antiviral Res; 2017 Apr; 140():45-54. PubMed ID: 28087313
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Interpreting Thermodynamic Profiles of Aminoadamantane Compounds Inhibiting the M2 Proton Channel of Influenza A by Free Energy Calculations.
    Homeyer N; Ioannidis H; Kolarov F; Gauglitz G; Zikos C; Kolocouris A; Gohlke H
    J Chem Inf Model; 2016 Jan; 56(1):110-26. PubMed ID: 26690735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Influenza virus strains with a fusion threshold of pH 5.5 or lower are inhibited by amantadine. Brief report.
    Beyer WE; Ruigrok RW; van Driel H; Masurel N
    Arch Virol; 1986; 90(1-2):173-81. PubMed ID: 3089198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitor-sensitive and inhibitor-resistant influenza A2 virus populations.
    Barb K; Takátsy G
    Acta Microbiol Acad Sci Hung; 1972; 19(3):195-205. PubMed ID: 4677587
    [No Abstract]   [Full Text] [Related]  

  • 25. [Studies of the reproduction of amantadine-resistant variant of the influenza virus and its recombination with the classical fowl pest virus in cell cultures].
    Uzunova A; Petrova R
    Acta Microbiol Virol Immunol (Sofiia); 1976; 4():98-104. PubMed ID: 1007967
    [No Abstract]   [Full Text] [Related]  

  • 26. The molecular basis of the specific anti-influenza action of amantadine.
    Hay AJ; Wolstenholme AJ; Skehel JJ; Smith MH
    EMBO J; 1985 Nov; 4(11):3021-4. PubMed ID: 4065098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Biologic potential of amantadine-resistant influenza A virus in an avian model.
    Bean WJ; Threlkeld SC; Webster RG
    J Infect Dis; 1989 Jun; 159(6):1050-6. PubMed ID: 2723453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of new adamantane derivatives on experimental influenza infection in mice.
    Eşanu V; Prahoveanu E; Lăzărescu M; Borş AL
    Virologie; 1986; 37(2):107-9. PubMed ID: 3727392
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Antiviral effect of 1-aminoadamantane derivatives in vitro.
    Váczi L; Hankovszky H; Hideg K; Hadházy G
    Acta Microbiol Acad Sci Hung; 1973; 20(3):241-7. PubMed ID: 4361336
    [No Abstract]   [Full Text] [Related]  

  • 30. Amantadine-oseltamivir combination therapy for H5N1 influenza virus infection in mice.
    Ilyushina NA; Hoffmann E; Salomon R; Webster RG; Govorkova EA
    Antivir Ther; 2007; 12(3):363-70. PubMed ID: 17591026
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inactivation of influenza and other viruses by a mixture of virucidal compounds.
    Oxford JS; Potter CW; McLaren C; Hardy W
    Appl Microbiol; 1971 Apr; 21(4):606-10. PubMed ID: 4102573
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic.
    Heider H; Adamczyk B; Presber HW; Schroeder C; Feldblum R; Indulen MK
    Acta Virol; 1981 Nov; 25(6):395-400. PubMed ID: 6120642
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterotypic protective immune reactions in mice infected with distinct serotypes of human influenza virus.
    Floc'h F; Werner GH
    Ann Microbiol (Paris); 1978; 129(4):509-24. PubMed ID: 308787
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Amantadine resistance in clinical influenza A (H3N2) and (H1N1) virus isolates.
    Pemberton RM; Jennings R; Potter CW; Oxford JS
    J Antimicrob Chemother; 1986 Oct; 18 Suppl B():135-40. PubMed ID: 3793655
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Amantadine-resistant influenza A virus in Taiwan.
    Shih SR; Lee CN; Tsai HR; Chen GW; Tsao KC
    J Formos Med Assoc; 2001 Sep; 100(9):608-12. PubMed ID: 11695276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amantadine resistance among porcine H1N1, H1N2, and H3N2 influenza A viruses isolated in Germany between 1981 and 2001.
    Schmidtke M; Zell R; Bauer K; Krumbholz A; Schrader C; Suess J; Wutzler P
    Intervirology; 2006; 49(5):286-93. PubMed ID: 16809934
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Rapid method of producing influenza A virus variants resistant to amantadine and remantadine and their primary characteristics].
    Vladyko AS; Shobukhov VM; Linitskaia GL; Galegov GA
    Vopr Virusol; 1982; 27(4):426-32. PubMed ID: 7135921
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Specific inhibitors of influenza virus replication as potential chemoprophylactic agents.
    Oxford JS
    J Antimicrob Chemother; 1975 Mar; 1(1):7-23. PubMed ID: 1100585
    [No Abstract]   [Full Text] [Related]  

  • 39. Amantadine resistance among hemagglutinin subtype 5 strains of avian influenza virus.
    Wainright PO; Perdue ML; Brugh M; Beard CW
    Avian Dis; 1991; 35(1):31-9. PubMed ID: 1827579
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Emergence of drug-resistant influenza virus: population dynamical considerations.
    Regoes RR; Bonhoeffer S
    Science; 2006 Apr; 312(5772):389-91. PubMed ID: 16627735
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.